UK Parliament / Open data

Public Health

Proceeding contribution from Rachel Hopkins (Labour) in the House of Commons on Wednesday, 6 January 2021. It occurred during Debates on delegated legislation on Public Health.

First, I thank our dedicated and brilliant scientists who have given us the hope of a way out of this extremely difficult period.

At the start of the first lockdown, the Prime Minister stated that the virus would be under control within 12 weeks, yet 10 months on, we are rerunning the devastation caused at the inception of the crisis. The virus is spreading exponentially, many people are in hospital and thousands of lives are at risk. This lockdown is necessary to restrict the spread of the virus and to protect our NHS, and yet again the public—my constituents in Luton South—at very short notice are doing their bit to tackle the spread of covid-19. But lockdown is a blunt tool. Being able to move out of it is contingent on the success of the vaccination programme across the country, so the Government must ensure that they carry out their side of the deal effectively, by acting quickly to make sure the programme is a success.

Meeting the target of vaccinating those in the top four priority groups by mid-February will require the vaccination of 2 million people a week and a total of 14 million vaccinations. Although we all want the vaccine to be rolled out as quickly as possible, I am concerned about the capacity of the UK’s vaccine manufacturers to meet that target, given that the sustained lack of investment in vaccine manufacturing has left the UK acutely underprepared. The chief medical officer has stated that the vaccine shortage is a reality that cannot be wished away, and the Government recognise that, having already dropped the 30 million dose vaccine target set in May.

At the beginning of 2020, the UK did not have the capacity to produce vaccines to meet the demand created by a pandemic, so, shockingly, we are seeing the UK relying on repurposed infrastructure to make the Oxford vaccine. Sir John Bell has stated:

“The government has been completely disinterested in building onshore manufacturing capacity for any of the life-sciences products”.

In addition, one of the companies manufacturing the AstraZeneca vaccine in bulk is transporting vaccine doses to Germany to be put in vials. A decade of Government austerity has hampered our ability to tackle this pandemic, and after the Government’s failures in PPE procurement and the outsourced test and trace system, and their failure to provide sufficient economic

support, particularly to those who have been excluded, they must now not fail in the roll-out of the vaccine programme. I hope the Minister will explain to the House how the Government intend to address the frailty of the vaccine manufacturing supply chain and to rapidly increase the number of doses available.

I am also concerned that the Government have not published a detailed strategy for the vaccination of all key workers. As we go into another lockdown, we will once again see the real value of key workers, who keep our country going. There have not been sufficient assurances that teachers, posties, firefighters, police officers—all frontline key workers—will be prioritised in the vaccination process. Will the Minister outline—

About this proceeding contribution

Reference

686 cc848-9 

Session

2019-21

Chamber / Committee

House of Commons chamber
Back to top